Penumbra Inc. (PEN)
Summary
Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain?
PEN gains CE Mark in Europe for THUNDERBOLT, expanding stroke treatment access and advancing its global stroke care strategy.
Why Is Penumbra (PEN) Down 1.2% Since Last Earnings Report?
Penumbra (PEN) reported earnings 30 days ago. What's next for the stock?
Penumbra (PEN) Misses Q1 Earnings Estimates
Penumbra (PEN) came out with quarterly earnings of $0.82 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.83 per share a year ago.
Penumbra Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 4 | $1,013.29 | $1,268.04 | $254.75 | 25.14% |
| ABB Alexander Bjornager Bonde Danske Bank A/S | 40 | $12,436.4 | $12,680.4 | $244 | 1.96% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 2 | $639.28 | $634.12 | -$5.16 | -0.81% |
 George Soros Soros Fund Management LLC | 203,434 | $66.8M | $64.51M | -$2.29M | -3.44% |
| BG Bart Gancher Intech Investment Management LLC | 7,237 | $1.84M | $2.29M | $456,722.95 | 24.85% |
Penumbra Inc. (PEN) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Penumbra Inc. ever had a stock split?
Penumbra Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Adam Elsesser CEO | NYSE Exchange | 70975L107 CUSIP |
| US Country | 4,600 Employees | - Last Dividend | 16 Nov 2014 Last Split | 18 Sep 2015 IPO Date |
Overview
Penumbra, Inc., together with its subsidiaries, is a healthcare company that specializes in the design, development, manufacture, and marketing of innovative medical devices. The company has a global presence, providing its wide range of products across the United States and internationally. Established in 2004 and based in Alameda, California, Penumbra is committed to improving patient care by offering solutions for various medical conditions, particularly in the fields of thrombectomy and embolization. It operates through direct sales organizations and distributors, making its advanced medical technologies accessible to healthcare professionals around the world.
Products and Services
Penumbra Inc.'s portfolio of medical devices is extensive and caters to several healthcare needs, particularly in vascular and neurovascular therapies. Below is a detailed look at some of their key products and services:
- Peripherals:
- Indigo System: A power aspiration system designed for thrombus removal in peripheral vessels.
- Lightning Flash, Lightning Bolt 7: Mechanical thrombectomy systems aimed at arterial thrombectomy, enhancing the removal of blood clots.
- CAT RX: Another product contributing to the company's thrombectomy solutions.
- Access Products:
- Guide Catheters and Penumbra Distal Delivery Catheters: Sold under various brands (e.g., Neuron, Neuron MAX Select, BENCHMARK), these access products facilitate the delivery of therapy with precision.
- Penumbra System:
- A comprehensive mechanical thrombectomy system that includes reperfusion catheters, separators, and the Penumbra ENGINE, among others, branded under names such as Penumbra RED, JET, ACE. Specifically designed for neurovascular applications.
- Neuro Embolization Coiling Systems:
- Includes products such as the Penumbra Coil 400 and Penumbra SMART COIL, aiming at treating neurovascular lesions and aneurysms.
- Peripheral Embolization Products:
- Ruby Coil System, Penumbra LANTERN Delivery Microcatheter, POD System, Packing Coil: These products offer solutions for peripheral embolization, providing tools for various medical interventions.
- Immersive 3D Computer-Based Technology Platform:
- Marketed under the real immersive system brand, it offers a novel approach to medical education and procedural planning.
- Neurosurgical Tools:
- Artemis Neuro Evacuation Device: Designed for the surgical removal of fluid and tissue from the brain, this tool underscores Penumbra’s innovation in neurosurgery.
